10/25/2013

Notice for Large Volume Exercise of the 37th Round of Stock Options

10/24/2013

Notice of Payment for the 37th Round of Stock Options and Partial Acquisition and Cancellation of 37th Round of Stock Options

10/07/2013

GNI Announces Acquisition and Cancellation of Stock Acquisition Rights (Third Party Allotment)-Thirty-Sixth Series and Issuance of Stock Acquisition Rights (Third Party Allotment)-Thirty-Seventh Series and Execution of the Third Party Allotment Agreement

10/01/2013

Notice for Exercise of the 36th Round of Stock Options in September, 2013

09/06/2013

Notice for Patent Grant in Canada and India

09/02/2013

Notice for Exercise of the 36th Round of Stock Options in August, 2013

08/30/2013

Notice of New Executive Officer

08/01/2013

Notice for Exercise of the 36th Round of Stock Options in July, 2013

08/01/2013

Notice of Establishment of an Affiliate Company (middle holding company)

07/01/2013

Notice for Exercise of the 36th Round of Stock Options in June, 2013

07/01/2013

Notice of Concluding LOI regarding Establishment of an Affiliate Company (middle holding company)

07/01/2013

Notice of Changing Representative

06/28/2013

Completion of F351 Ib clinical trials and receiving manufacture method patent approval for F351 in China.

06/10/2013

Notice of Payment for the 36th Round of Stock Options

06/07/2013

Receipt of Grant Notice and Record of Non-Operation Income at Shanghai Genomics Inc.